SRTS Company Profile and Key Details
Sensus Healthcare
Price Chart
Stock Price Today
Sensus Healthcare, Inc. (SRTS) stock declined over -0.93%, trading at $3.20 on NASDAQ, down from the previous close of $3.23. The stock opened at $3.23, fluctuating between $3.16 and $3.29 in the recent session.
Stock Snapshot
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 21, 2026 | 3.28 | 3.29 | 3.10 | 3.23 | 44.22K |
| May 20, 2026 | 3.34 | 3.55 | 3.22 | 3.32 | 32.86K |
| May 19, 2026 | 3.46 | 3.46 | 3.32 | 3.35 | 23.44K |
| May 18, 2026 | 3.53 | 3.58 | 3.42 | 3.47 | 40.28K |
| May 15, 2026 | 3.65 | 3.70 | 3.43 | 3.61 | 44.64K |
| May 14, 2026 | 3.39 | 3.64 | 3.35 | 3.61 | 97.02K |
| May 13, 2026 | 3.37 | 3.50 | 3.26 | 3.45 | 41.23K |
| May 12, 2026 | 3.41 | 3.51 | 3.25 | 3.37 | 56.21K |
| May 11, 2026 | 3.29 | 3.59 | 3.14 | 3.41 | 135.69K |
| May 08, 2026 | 3.07 | 3.33 | 2.82 | 3.08 | 663.87K |
| May 07, 2026 | 4.24 | 4.28 | 4.02 | 4.11 | 66.75K |
| May 06, 2026 | 3.98 | 4.18 | 3.85 | 4.09 | 138.11K |
| May 05, 2026 | 4.00 | 4.00 | 3.91 | 3.93 | 40.69K |
| May 04, 2026 | 4.03 | 4.20 | 3.80 | 3.96 | 118.05K |
| Apr 30, 2026 | 3.86 | 4.05 | 3.81 | 3.97 | 28.32K |
| Apr 29, 2026 | 3.88 | 3.99 | 3.80 | 3.90 | 13.07K |
| Apr 28, 2026 | 4.00 | 4.03 | 3.87 | 3.89 | 14.93K |
| Apr 27, 2026 | 3.94 | 4.07 | 3.94 | 3.96 | 14.34K |
| Apr 23, 2026 | 4.00 | 4.02 | 3.89 | 3.93 | 28.54K |
| Apr 22, 2026 | 4.02 | 4.10 | 3.92 | 4.04 | 23.7K |
Contact Details
About Company
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Company Information
| Employees | 54 |
| Beta | 1.29 |
| Sales or Revenue | $24.41M |
| 5Y Sales Change% | -0.198% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Stock Peers
Frequently Asked Questions
Chief Operating Officer
Mr. Javier Rampolla
Chief Financial Officer
Mr. Joseph C. Sardano
Co-Founder, Chairman & Chief Executive Officer
Mr. Benson Suen
Vice President of International Sales
Dr. Clay Jefferies Cockerell
Clinical Director & Member of Medical Advisory Board
Dr. Mark S. Nestor
Medical Director & Member of Medical Advisory Board
Mr. Michael J. Sardano
Pres, Gen. Counsel & Corporation Sec.
Ms. Magdalena Martinez
Chief Operating Officer
Ms. Stephanie Tipton
Vice President of Marketing
Mr. Emiliano Sosa
Chief Technology Officer
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep